$Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center$

Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center

Bibliographic Details
Main Authors:	Jesko Momotow, Helen Goergen, Karolin Behringer, Paul J. Bröckelmann, Sven Borchmann, Bastian v. Tresckow, Carsten Kobe, Andreas Engert, Stephanie Sasse
Format:	Article
Language:	English
Published:	Wolters Kluwer 2019-10-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000293

Internet

http://journals.lww.com/10.1097/HS9.0000000000000293

Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center

Internet

Similar Items